• Referral to GEDI Infusion Center

  • What to Expect: 

    Once this COVID Treatment referral is submitted, based on your patient's risk profile for progression to severe disease, they will be allocated to receive either one of our monoclonal antibodies or an oral antiviral therapy. It’s important to note that based on available data there appears to be poor invitro efficacy of regeneron or Eli Lilly monoclonal antibody for omicron, hence not recommended as a treatment option at this time for high-risk patients


     


  •  - -
  •  - -
  • Please answer the questions below:

  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Should be Empty: